Lancet Oncology, 22, 29-42 Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC the RAPIDO collaborative investigators 2021, ' Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial ', The Lancet Oncology, vol. 22, no. 1, pp. 29-42 . https://doi.org/10.1016/S1470-2045(20)30555-6 The Lancet Oncology, 22(1), 29-42. ELSEVIER SCIENCE INC The Lancet. Oncology r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA instname Lancet Oncology, 22, 1, pp. 29-42 The Lancet Oncology, 22(1), 29-42. ELSEVIER The Lancet Oncology, 22(1), 29-42. Lancet Publishing Group lancet oncology, 22(1), 29-42. Lancet Publishing Group
Tveit, K M, Guren, T, Glimelius, B, Pfeiffer, P, Sorbye, H, Pyrhonen, S, Sigurdsson, F, Kure, E, Ikdahl, T, Skovlund, E, Fokstuen, T, Hansen, F, Hofsli, E, Birkemeyer, E, Johnsson, A, Starkhammar, H, Yilmaz, M K, Keldsen, N, Erdal, A B, Dajani, O, Dahl, O & Christoffersen, T 2012, ' Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer : The NORDIC-VII Study ', Journal of Clinical Oncology, vol. 30, no. 15, pp. 1755-62 . https://doi.org/10.1200/JCO.2011.38.0915 Tveit, K M, Guren, T, Glimelius, B, Pfeiffer, P, Sorbye, H, Pyrhonen, S, Sigurdsson, F, Kure, E, Ikdahl, T, Skovlund, E, Fokstuen, T, Hansen, F, Hofsli, E, Birkemeyer, E, Johnsson, A, Starkhammar, H, Yilmaz, M K, Keldsen, N, Erdal, A B, Dajani, O, Dahl, O & Christoffersen, T 2012, ' Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer : the NORDIC-VII study ', Journal of Clinical Oncology, vol. 30, no. 15, pp. 1755-1762 . https://doi.org/10.1200/JCO.2011.38.0915
Qvortrup, C, Jensen, B V, Fokstuen, T, Nielsen, S E, Keldsen, N, Glimelius, B, Bjerregaard, B, Mejer, J, Larsen, F O & Pfeiffer, P 2009, ' A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX30 and chronomodulated XELOX30 as first-line therapy in patients with advanced colorectal cancer ', Annals of Oncology, vol. 21, no. 1, pp. 87-91 . https://doi.org/10.1093/annonc/mdp272